ArticleScientific reports2021

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection.

Agata Antepowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.